[Tree] Regulatory challenges faced by healthcare private equity investors

Version 0.06 (2024-08-19 13:39:59.916000)

updates: Increased scrutiny from regulators and market dynamics

  • ➔
  • ➔
  • ➔
Version 0.05 (2024-04-09 20:18:59.902000)

updates: New information about the risks of private equity in cardiology and other specialties, the concerns raised by the Private Equity Stakeholder Project (PESP) and U.S. Senator Elizabeth Warren, and the negative opinions of physicians about the influence of private equity in cardiology

  • ➔
  • ➔
Version 0.04 (2023-12-15 18:57:58.658000)

updates: Integration of information about Key Person Events in private equity funds

  • ➔
Version 0.03 (2023-11-25 16:45:34.927000)

updates: Private equity overvaluation and risk to retirement funds

  • ➔
  • ➔
  • ➔
Version 0.02 (2023-11-25 06:42:37.314000)

updates: Integration of new information about the collapse of Southland Royalty and the concerns about private equity valuations

  • ➔
  • ➔
Version 0.01 (2023-11-19 06:18:21.160000)

updates: Generali executive warns about risks of private equity funds in insurance

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.0 (2023-11-13 13:53:16.649000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔